The Reply - 04/05/21
Doi : 10.1016/j.amjmed.2020.11.033
Antonios Vitalis, MD, MRCS a, b, c, Alena Shantsila, PhD a, Gregory Y.H. Lip, MD a, d, ⁎ 
a Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK
b Institute of Cardiovascular Sciences, University of Birmingham, UK
c Department of Vascular Surgery, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, UK
d Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
⁎Requests for reprints should be addressed to Gregory Y. H. Lip, MD, Price-Evans Professor of Cardiovascular Medicine, University of Liverpool, William Henry Duncan Building, 6 West Derby Street, Liverpool, L7 8TX, UK.Price-Evans Professor of Cardiovascular MedicineUniversity of LiverpoolWilliam Henry Duncan Building, 6 West Derby StreetLiverpoolL7 8TXUK
Le texte complet de cet article est disponible en PDF.
| Funding: None. |
|
| Conflict of Interest: GYHL reports serving as consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon and Daiichi-Sankyo; a speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo; however, no fees are directly received personally. AC, AS report none. |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. |
© 2021
Elsevier Inc. Tous droits réservés.
Vol 134 - N° 5
P. e354-e355 - mai 2021 Retour au numéro
Article précédent
- High-Grade Carotid Artery Stenosis and Atrial Fibrillation
- Oscar M.P. Jolobe
- Salt for Patients with Heart Failure and Hyponatremia?
- Rinkoo Dalan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?